IL3 and myeloproliferative neoplasm: The selectivity of the MPN-evaluated JAKinibs towardJAK2 V617F,the most frequent gain-of-function mutation in MPN patients, was studiedin the IL-3-dependent cell line Ba/F3, a well-established model systemfor cytokine receptor studies.